{"id":515252,"date":"2021-07-20T16:04:06","date_gmt":"2021-07-20T20:04:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/"},"modified":"2021-07-20T16:04:06","modified_gmt":"2021-07-20T20:04:06","slug":"aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/","title":{"rendered":"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase"},"content":{"rendered":"

<\/p>\n

Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase<\/b><\/p>\n

DURHAM, N.C.–(BUSINESS WIRE<\/a>)–
\nAerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that David A. Hollander, M.D., M.B.A., Chief Research & Development Officer presented an overview on Aerie\u2019s globalization outlook at the Ophthalmology Innovation Summit European Innovation Showcase. The slide presentation includes an overview on Aerie\u2019s approach to Europe for both its glaucoma franchise and Aerie\u2019s product candidates.\n<\/p>\n

\nThe slide presentation from today\u2019s event is available now and may be accessed by visiting Aerie\u2019s website at http:\/\/investors.aeriepharma.com<\/a>.\n<\/p>\n

About Aerie Pharmaceuticals, Inc.<\/b><\/p>\n

\nAerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases. Aerie\u2019s first product, Rhopressa\u00ae<\/sup> (netarsudil ophthalmic solution) 0.02%, a once-daily eye drop approved by the U.S. Food and Drug Administration (FDA) for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension, was launched in the United States in April 2018. In clinical trials of Rhopressa\u00ae<\/sup>, the most common adverse reactions were conjunctival hyperemia, corneal verticillata, instillation site pain, and conjunctival hemorrhage. More information about Rhopressa\u00ae<\/sup>, including the product label, is available at www.rhopressa.com<\/a>. Aerie\u2019s second product for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension, Rocklatan\u00ae<\/sup> (netarsudil and latanoprost ophthalmic solution) 0.02%\/0.005%, the first and only fixed-dose combination of Rhopressa\u00ae<\/sup> and the widely-prescribed PGA (prostaglandin analog) latanoprost, was launched in the United States in May 2019. In clinical trials of Rocklatan\u00ae<\/sup>, the most common adverse reactions were conjunctival hyperemia, corneal verticillata, instillation site pain, and conjunctival hemorrhage. More information about Rocklatan\u00ae<\/sup>, including the product label, is available at www.rocklatan.com<\/a>. Aerie continues to focus on global expansion and the development of additional product candidates and technologies in ophthalmology, including for wet age-related macular degeneration and diabetic macular edema. More information is available at www.aeriepharma.com<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210720005141\/en\/<\/a><\/span><\/p>\n

\nMedia: Tad Heitmann 949-526-8747; theitmann@aeriepharma.com
\n<\/a>
Investors: Ami Bavishi 908-947-3949; abavishi@aeriepharma.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America North Carolina<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Optical Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase DURHAM, N.C.–(BUSINESS WIRE)– Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that David A. Hollander, M.D., M.B.A., Chief Research & Development Officer presented an overview on Aerie\u2019s globalization outlook at the Ophthalmology Innovation Summit European Innovation Showcase. The slide presentation includes an overview on Aerie\u2019s approach to Europe for both its glaucoma franchise and Aerie\u2019s product candidates. The slide presentation from today\u2019s event is available now and may be accessed by visiting Aerie\u2019s website at http:\/\/investors.aeriepharma.com. About Aerie Pharmaceuticals, Inc. Aerie … <\/p>\n

Continue reading “Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-515252","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase DURHAM, N.C.–(BUSINESS WIRE)– Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that David A. Hollander, M.D., M.B.A., Chief Research & Development Officer presented an overview on Aerie\u2019s globalization outlook at the Ophthalmology Innovation Summit European Innovation Showcase. The slide presentation includes an overview on Aerie\u2019s approach to Europe for both its glaucoma franchise and Aerie\u2019s product candidates. The slide presentation from today\u2019s event is available now and may be accessed by visiting Aerie\u2019s website at http:\/\/investors.aeriepharma.com. About Aerie Pharmaceuticals, Inc. Aerie … Continue reading "Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-20T20:04:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210720005141r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase\",\"datePublished\":\"2021-07-20T20:04:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/\"},\"wordCount\":419,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210720005141r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/\",\"name\":\"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210720005141r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-07-20T20:04:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210720005141r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210720005141r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/","og_locale":"en_US","og_type":"article","og_title":"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase - Market Newsdesk","og_description":"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase DURHAM, N.C.–(BUSINESS WIRE)– Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that David A. Hollander, M.D., M.B.A., Chief Research & Development Officer presented an overview on Aerie\u2019s globalization outlook at the Ophthalmology Innovation Summit European Innovation Showcase. The slide presentation includes an overview on Aerie\u2019s approach to Europe for both its glaucoma franchise and Aerie\u2019s product candidates. The slide presentation from today\u2019s event is available now and may be accessed by visiting Aerie\u2019s website at http:\/\/investors.aeriepharma.com. About Aerie Pharmaceuticals, Inc. Aerie … Continue reading \"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-20T20:04:06+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210720005141r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase","datePublished":"2021-07-20T20:04:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/"},"wordCount":419,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210720005141r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/","name":"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210720005141r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-07-20T20:04:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210720005141r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210720005141r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aerie-pharmaceuticals-announces-presentation-at-the-ophthalmology-innovation-summit-european-innovation-showcase\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=515252"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/515252\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=515252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=515252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=515252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}